Antigen levels of CATB, CATL, uPA, PAI-1 and CEA, CA 19-9 levels showed a trend toward higher levels in patients with colon cancer compared to patients with rectal cancer, but the differences were not statistically significant (data not shown). The gene discussed is SERPINE1; the disease is colonic neoplasm.